TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 616037650

Group type: EXPERIMENTAL
Intervention: 0.2 mug/day fluocinolone acetonide (FAc)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study: 37904790

Group type: EXPERIMENTAL
Intervention: Dynamic Capener orthosis
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Static progressive belly gutter orthosis
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Serial cast orthosis
Number of subjects: 61

Group type: COMPARATOR
Intervention: All orthosis types
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Abbreviated Weeks test (WT) assessment
Number of subjects: 61
Study: 33228979

Group type: COMPARATOR
Intervention: Control (clinical judgement)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SPI (surgical pleth index)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: PPI (pupillary pain index)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: NOL (nociception level)
Number of subjects: 96
Study: 32349268

Group type: EXPERIMENTAL
Intervention: MyGoals for Healthy Aging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delphi method
Number of subjects: 0
Study: 34608769

Group type: EXPERIMENTAL
Intervention: Imatinib in patients with COVID-19
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: AAG-PK-Model with AAG concentrations
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Covariate modeling including AAG, age, bodyweight, albumin, CRP, and ICU admission
Number of subjects: 134
Study: 36414504

Group type: EXPERIMENTAL
Intervention: IA‐PRP
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: IA+IO‐PRP
Number of subjects: 96

Group type: COMPARATOR
Intervention: IA‐NS
Number of subjects: 96
Study: 34360299

Group type: EXPERIMENTAL
Intervention: FaCoT intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 66
Study: 32593489

Group type: EXPERIMENTAL
Intervention: Mouth Care Without a Battle (MCWB) program
Number of subjects: 14
Study: 35910688

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT) intervention
Number of subjects: 49
Study: 32113466

Group type: EXPERIMENTAL
Intervention: Simparica Trio™ (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sarolaner-alone (1.2 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moxidectin-alone (24 µg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pyrantel-alone (5 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simparica Trio™
Number of subjects: 0
Study: 36045484

Group type: EXPERIMENTAL
Intervention: LY06006 (60 mg)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Denosumab (60 mg)
Number of subjects: 168
Study: 33168433

Group type: EXPERIMENTAL
Intervention: EluNIR™ ridaforolimus‐eluting stent (RES)
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Resolute™ zotarolimus‐eluting stent (ZES)
Number of subjects: 1910

Group type: COMPARATOR
Intervention: Both RES and ZES
Number of subjects: 1910
Study: 34463234

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) and sertraline (SERT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT) and pill placebo
Number of subjects: 99
Study: 35962142

Group type: EXPERIMENTAL
Intervention: Prolonged (week‐long) daily administration of the SSRI citalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute (single‐dose) administration of the SSRI citalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33377959

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard fluid therapy
Number of subjects: 283
Study: 34139041

Group type: EXPERIMENTAL
Intervention: Neoadjuvant Chemoradiotherapy (NCRT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Definitive Chemoradiotherapy (DCRT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neoadjuvant Chemoradiotherapy (NCRT) followed by surgery
Number of subjects: 83
Study: 34239129

Group type: EXPERIMENTAL
Intervention: Proteins implicated in neurological diseases (identified through Mendelian randomization)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brain
Number of subjects: 0
Study: 32766304

Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model with different adjusted weights
Number of subjects: 1779

Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model
Number of subjects: 1779
Study: 35545584

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii combined with triple therapy for 14 days and triple therapy for 10 days
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Bismuth quadruple therapy for 10 days
Number of subjects: 497

Group type: COMPARATOR
Intervention: Standard triple therapy for 10 days
Number of subjects: 497
Study: 32318736

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32929463

Group type: EXPERIMENTAL
Intervention: MRI-targeted treat‐to‐target strategy
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Baseline MRI osteitis
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Baseline tenosynovitis
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Low tender joint count and low patient visual analogue scale pain and global
Number of subjects: 171

Group type: COMPARATOR
Intervention: Conventional synthetic DMARDs
Number of subjects: 171
Study: 32118723

Group type: EXPERIMENTAL
Intervention: LISA (less invasive surfactant administration via gastric tube)
Number of subjects: 97

Group type: COMPARATOR
Intervention: INSURE (intubation-surfactant-extubation)
Number of subjects: 97
Study: 34551907

Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (Azacitidine and Decitabine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Investigational agents (less active)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytostatic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Agents manipulating pyrimidine metabolism
Number of subjects: 0
Study: 32585670

Group type: EXPERIMENTAL
Intervention: Sucroferric oxyhydroxide (SFOH) or sevelamer carbonate (sevelamer) for 52 weeks
Number of subjects: 497

Group type: COMPARATOR
Intervention: Not applicable (pooled treatment groups)
Number of subjects: 497
Study: 35695671

Group type: EXPERIMENTAL
Intervention: Colored indicator under glove
Number of subjects: 476

Group type: COMPARATOR
Intervention: Regular outer glove
Number of subjects: 476
Study: 32941737

Group type: EXPERIMENTAL
Intervention: Ketone monoester (KME) supplement (0.45 mL/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 32755265

Group type: EXPERIMENTAL
Intervention: Cognitive-narrative therapy (4 sessions)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 19
Study: 32977253

Group type: EXPERIMENTAL
Intervention: AS1000 group (L‐arginine, 1 g; folate, 200 μg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: AS2000 group (L‐arginine, 2 g; folate, 400 μg; vitamin E, 10 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Global L‐arginine group (AS1000 and AS2000)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: L‐arginine groups (AS1000 and AS2000) in male infertility subgroup
Number of subjects: 120
Study: 35014217

Group type: EXPERIMENTAL
Intervention: GDC-0134 (up to 1200 mg daily)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: GDC-0134
Number of subjects: 49

Group type: COMPARATOR
Intervention: DLK conditional knockout (cKO) mice
Number of subjects: 49
Study: 34416736

Group type: EXPERIMENTAL
Intervention: Decompression with instrumented fusion
Number of subjects: 84

Group type: COMPARATOR
Intervention: Decompression
Number of subjects: 84
Study: 32456442

Group type: EXPERIMENTAL
Intervention: EPs 7630, 3 × 20 mg/day for 10 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Amoxicillin, 3 × 500 mg/day for 10 days
Number of subjects: 50
Study: 35901595

Group type: EXPERIMENTAL
Intervention: F/TMP association (1100 ppm F + 3 % TMP)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 3 % TMP (hydrolyzed or not)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 500 ppm F
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 1100 ppm F
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 1100 ppm F + 3 % TMP
Number of subjects: 130

Group type: COMPARATOR
Intervention: F/TMP association
Number of subjects: 130
Study: 33581381

Group type: EXPERIMENTAL
Intervention: Stochastic configuration networks (SCNs) ensemble models
Number of subjects: 0
Study: 34642798

Group type: EXPERIMENTAL
Intervention: Video-assisted mediastinoscopic combined with laparoscopic transhiatal esophagectomy (VAME)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Video-assisted thoracoscopic esophagectomy (VATE)
Number of subjects: 200
Study: 32152813

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 3.0 g via subfascial drain
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous tranexamic acid (TXA) 1.5 g just before wound closure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical and IV TXA
Number of subjects: 60
Study: 32943381

Group type: EXPERIMENTAL
Intervention: AC resection arthroplasty (DCR) in shoulders with T2 hyperintensity (HI+)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Shoulders without T2 hyperintensity (HI−)
Number of subjects: 107
Study: 35599154

Group type: COMPARATOR
Intervention: BCG vaccine
Number of subjects: 378
Study: 34319137

Group type: EXPERIMENTAL
Intervention: Maternal vaccination against PNAG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-vaccinated foals)
Number of subjects: 0
Study: 32000724

Group type: EXPERIMENTAL
Intervention: HAI oxaliplatin plus systemic FOLFIRI plus targeted therapy (anti-EGFR antibody or bevacizumab)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional systemic chemotherapy (sys-CT) plus targeted therapy (anti-EGFR or antiangiogenic antibody)
Number of subjects: 140
Study: 34982817

Group type: EXPERIMENTAL
Intervention: Supplementary feeding
Number of subjects: 1791

Group type: COMPARATOR
Intervention: Counseling alone
Number of subjects: 1791
Study: 34224341

Group type: COMPARATOR
Intervention: Placebo delivery forms
Number of subjects: 277
Study: 35409483

Group type: EXPERIMENTAL
Intervention: Peer support plus daily text messages
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Text messaging only
Number of subjects: 181

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 181

Group type: COMPARATOR
Intervention: Peer support only
Number of subjects: 181

Group type: COMPARATOR
Intervention: Daily supportive text messages only
Number of subjects: 181
Study: 33412465

Group type: EXPERIMENTAL
Intervention: Axitinib 5 mg twice daily and pembrolizumab 2 mg/kg every 3 weeks
Number of subjects: 52
Study: 35509077

Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine (0-2-6 months)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine (0-2-12 months)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine (both schedules)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (0-2-6 group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (0-2-12 group)
Number of subjects: 200
Study: 32181599

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in PDAC patients after surgery
Number of subjects: 6323

Group type: COMPARATOR
Intervention: Nomograms compared to the 8th edition AJCC staging system
Number of subjects: 6323
Study: 34262664

Group type: EXPERIMENTAL
Intervention: Developmentally adapted cognitive processing therapy (D-CPT)
Number of subjects: 44
Study: 34955090

Group type: EXPERIMENTAL
Intervention: Touch condition (actual hold touched)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-touch condition (actual hold not touched)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-Prime condition (SP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double-Prime condition (DP)
Number of subjects: 0
Study: 32869586

Group type: EXPERIMENTAL
Intervention: Interaction of twelve meridian muscle regions and contralateral needling therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intramuscular injection of mecobalamine and oral citicoline sodium capsules
Number of subjects: 46
Study: 32366139

Group type: EXPERIMENTAL
Intervention: Industrial beer (4.5% alcohol), 330 ml daily for 3 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Craft beer (9% alcohol), 330 ml daily for 3 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as the absence of beer consumption)
Number of subjects: 24
Study: 35028547

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) - 25% reduction from baseline calorie intake for 24 months
Number of subjects: 218

Group type: COMPARATOR
Intervention: Ad libitum (AL)
Number of subjects: 218
Study: 33297445

Group type: EXPERIMENTAL
Intervention: Dengue seroconversion
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Seroprevalence of dengue
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Association with age and gender
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Association with province and duration of residence
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Socioeconomic factors and mosquito control methods
Number of subjects: 1071
Study: 33105359

Group type: EXPERIMENTAL
Intervention: Full-Body (FB) resistance exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lower-Body (LB) resistance exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Upper-Body (UB) resistance exercise
Number of subjects: 12
Study: 36461019

Group type: EXPERIMENTAL
Intervention: Parenting intervention through 'Care for Child Development Guideline' (5 educational group sessions, each lasting 45 minutes)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 181
Study: 33430922

Group type: EXPERIMENTAL
Intervention: Joint didactic intervention using the Junta de Andalucía School for Patients method
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual clinical practice (Control group)
Number of subjects: 312
Study: 35900802

Group type: EXPERIMENTAL
Intervention: High-intensity (HI) bench press protocol (5 sets of 1 rep at 90% of 1RM)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: High-power (POW) bench press protocol (5 sets of 1 rep at 30% of 1RM with maximum explosive intent)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control trial (CON)
Number of subjects: 13
Study: 33999281

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 856
Study: 35227810

Group type: EXPERIMENTAL
Intervention: Unicompartmental knee arthroplasty (UKA)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 107
Study: 32910549

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventionally fractionated chemoradiation (CRT)
Number of subjects: 80
Study: 35915802

Group type: EXPERIMENTAL
Intervention: Enteral nutrition support on a routine basis
Number of subjects: 200

Group type: COMPARATOR
Intervention: Parenteral nutrition support on a routine basis
Number of subjects: 200
Study: 34216395

Group type: EXPERIMENTAL
Intervention: EVR+rCNI
Number of subjects: 293

Group type: COMPARATOR
Intervention: MPA+sCNI
Number of subjects: 293
Study: 32716291

Group type: EXPERIMENTAL
Intervention: Rizatriptan oral gel (test)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Rizatriptan oral lyophilisate (reference)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Test vs Reference (T/R)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Palatability assessment of the new product
Number of subjects: 47
Study: 35017204

Group type: EXPERIMENTAL
Intervention: EVT‐alone
Number of subjects: 656
Study: 34521975

Group type: EXPERIMENTAL
Intervention: Neonatal Adverse Event Severity Scale (NAESS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Generic and AE-specific NAESS tables
Number of subjects: 60
Study: 36041760

Group type: EXPERIMENTAL
Intervention: FDCC integrated hub model of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32778372

Group type: EXPERIMENTAL
Intervention: Web-based classroom gaming
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33728385

Group type: EXPERIMENTAL
Intervention: Aayudh Advance (herbal formulation)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard of Care treatment
Number of subjects: 74
Study: 32586639

Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) with 3.2 mm diameter
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) with 6.4 mm diameter
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) with 9.6 mm diameter
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Variably occluded facemask (VOFM) for 5 minutes
Number of subjects: 15

Group type: COMPARATOR
Intervention: Historical patient group with 2 minutes phonation training
Number of subjects: 15
Study: 32560737

Group type: EXPERIMENTAL
Intervention: Direct Superior Approach (DSA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Posterior Approach (PA)
Number of subjects: 80
Study: 33484291

Group type: COMPARATOR
Intervention: Aerobic exercises at the anaerobic threshold (AT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Aerobic exercises above the anaerobic threshold (Over AT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Over AT group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (AT group)
Number of subjects: 57
Study: 35051978

Group type: EXPERIMENTAL
Intervention: 2-hour repositioning interval
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: 3-hour repositioning interval
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: 4-hour repositioning interval
Number of subjects: 992

Group type: COMPARATOR
Intervention: Baseline (before intervention)
Number of subjects: 992
Study: 34401778

Group type: EXPERIMENTAL
Intervention: Multisystem mapping training combined with post-training sleep consolidation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 35180728

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Long leg cast
Number of subjects: 44
Study: 34173157

Group type: EXPERIMENTAL
Intervention: High frequency (HF) dTMS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study: 36056399

Group type: EXPERIMENTAL
Intervention: Robotic walking rehabilitation treatment (experimental group)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional gait rehabilitation treatment (control group)
Number of subjects: 144
Study: 33836919

Group type: EXPERIMENTAL
Intervention: Microcephaly associated with Zika virus (MZV)
Number of subjects: 40
Study: 35810173

Group type: EXPERIMENTAL
Intervention: Gratitude expression treatment (GET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 34388099

Group type: EXPERIMENTAL
Intervention: AI imaging predictor (AIP)
Number of subjects: 869

Group type: EXPERIMENTAL
Intervention: Integrated clinical and AI imaging nomogram (ClAIN)
Number of subjects: 869

Group type: EXPERIMENTAL
Intervention: ClAIN
Number of subjects: 869
Study: 33221898

Group type: EXPERIMENTAL
Intervention: Antimicrobial prescriptions during inpatient admissions
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Antimicrobial prescriptions in neonatal sepsis
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Antimicrobial prescriptions in lower respiratory tract infection (LRTI)
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Use of 'Watch' antimicrobials in neonatal sepsis
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Use of 'Watch' antimicrobials in LRTI
Number of subjects: 1254

Group type: COMPARATOR
Intervention: Comparison of antimicrobial prescription rates
Number of subjects: 1254
Study: 35027160

Group type: EXPERIMENTAL
Intervention: Standardized positive mental imagery exercise about future public speaking
Number of subjects: 43

Group type: COMPARATOR
Intervention: No-task (control group)
Number of subjects: 43
Study: 34417443

Group type: EXPERIMENTAL
Intervention: Testosterone (0.50 mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 32790593

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 22
Study: 35240084

Group type: EXPERIMENTAL
Intervention: Multiparametric ultrasound
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Multiparametric MRI
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Combination of both tests
Number of subjects: 370
Study: 32049889

Group type: EXPERIMENTAL
Intervention: Intravenous tobramycin at 8:00 hours
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Intravenous tobramycin at 22:00 hours
Number of subjects: 25
Study: 34882964

Group type: EXPERIMENTAL
Intervention: DHEA (n = 410)
Number of subjects: 821

Group type: COMPARATOR
Intervention: Placebo (n = 411)
Number of subjects: 821
Study: 36260279

Group type: EXPERIMENTAL
Intervention: Hands‐eyes‐mouth distraction technique (HEM‐DT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Covering patient's vision technique (CPV‐T)
Number of subjects: 52
Study: 34399696

Group type: EXPERIMENTAL
Intervention: Restricted randomization procedures targeting 1:1 allocation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covariate‐adjusted analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization-based tests
Number of subjects: 0
Study: 32398119

Group type: EXPERIMENTAL
Intervention: 80% oxygen during surgery and for 2 h postoperatively
Number of subjects: 260

Group type: COMPARATOR
Intervention: 30% oxygen during surgery and for 2 h postoperatively
Number of subjects: 260